A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: listed (1000), planned (748), programmed (540)

Virtual Schedule on the day (June 2023)

Description
DOCTORS’ INDUCTION PROGRAMME Via MS TEAMs Topic Time Slots Registration 08:00 DME WELCOME 08:10 e-prescribing 08:30 Pharmac
Url
/Media/UHS-website-2019/Docs/Health-professionals/Education/Virtual-Schedule-on-the-day-June-2023.docx

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Aria ePrescribing v13.6 MR1.2 user training guide

Description
Aria E-Prescribing v13.6 MR1.2 User Training Guide Every effort has been made to ensure that the material in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/Aria-ePrescribing-v13.6-MR1.2-user-training-guide.pdf

CH003 regimen validation checklist ver2.0x

Description
Central South Coast Cancer Network Strength through Partnership Checklist for Verification of Treatment Regimens in ARIA Versi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003regimenvalidationchecklistver20x.pdf

Blinatumomab

Description
Chemotherapy Protocol Acute lymphoblastic leukaemia (ALL) Blinatumomab (3, 4 day) Regimen • ALL – Blinatumomab (3, 4 day schedule) Indication • Treatment of Philadelphia
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Blinatumomab.pdf

Papers Trust Board - 15 July 2025

Description
Agenda Trust Board – Open Session Date 15/07/2025 Time 9:00 - 13:00 Location Conference Room, Heartbeat Education C
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-15-July-2025.pdf

Annual report 2021-2022

Description
2021/22 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2021/22 Pr
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-2021-2022.pdf

Tarlatamab (EAMS)

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) Tarlatamab (EAMS) Regimen • SCLC – Tarlatamab (EAMS) Indication • T
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Tarlatamab-EAMS-Ver-1.0.pdf

HSCTMelphalan-Bortezomib IV

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT InP - MELPHALAN and BORTEZOMIB (IV) Please confirm correct protocol with transplant schedule Regimen • HSCT – InP - Melphalan
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-Bortezomib-IV.pdf

ACCORD-2 example sub-protocol

Description
CONFIDENTIAL ACCORD-2-002 - Sub protocol for Bemcentinib (Amendment 01) TITLE PAGE Master Protocol Title: ACCORD-2: A Multic
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-example-sub-protocol.pdf
1 to 10 of 450
Previous 1 2 3 4 5 … Next